Business Context and Reporting Period
This Form 8-K filing by Healthcare Trust, Inc. (the "Company") reports the determination of the Estimated Per-Share Net Asset Value ("Estimated Per-Share NAV") for its common stock. The valuation date is December 31, 2020, and the report date is March 31, 2021. The Company is a non-listed REIT focused on healthcare real estate assets.
Key Financial Metrics
The filing focuses on asset valuation rather than operational financial results (revenue, profit, cash flow). Key valuation metrics as of December 31, 2020, include:
- Estimated Per-Share NAV: $14.50 (approved by independent directors).
- Common Shares Outstanding: 94,181,653.
- Real Estate Assets Valuation Range: $26.29 (Low) to $28.09 (High) per share.
- Debt and Liabilities: Fair value of debt was estimated at $13.03 per share; other liabilities at $0.88 per share.
- Preferred Stock: Liquidation value of 7.375% Series A Preferred Stock was $0.43 per share.
- Asset Cost Basis Comparison: The midpoint valuation of real estate assets reflects a 6.7% decrease from the sum of original investment costs ($2.7 billion) and subsequent capital expenditures ($75.0 million).
Material Changes and Valuation Methodology
The valuation was performed by Duff & Phelps, LLC, an independent third-party firm. Key methodological details include:
- Valuation Approaches: The Direct Capitalization Method was used for 31 assets, and the Discounted Cash Flow Method for 153 assets. The Sales Comparison Approach was used for two land parcels, and disposition prices were used for six properties (including Florida properties and Michigan Shops).
- Impact of COVID-19: The valuation approach for 17 properties was changed from Direct Capitalization to Discounted Cash Flow due to irregular cash flows caused by the pandemic. The Board explicitly considered the impact of the pandemic on the final NAV.
- Board Decision: The Board selected $14.50, which is $0.47 above the midpoint ($14.03) of the Duff & Phelps range ($13.16 - $14.96). This decision considered the stock dividend issued in January 2021 and the valuation of properties held for sale.
Guidance, Risks, and Limitations
The filing contains significant disclosures regarding the limitations of the Estimated Per-Share NAV:
- Liquidity Discount: The NAV does not reflect a liquidity discount for the fact that shares are not traded on a national securities exchange.
- Market Value vs. NAV: The estimated values may not represent current market value or the price a third party would pay. The NAV does not represent "enterprise value."
- Risks: The Company highlights risks associated with the ongoing global COVID-19 pandemic, which could materially affect tenant operations and property values. Forward-looking statements are subject to uncertainties regarding interest rates and capital markets.
- Future Adjustments: The NAV will not be adjusted for future stock dividends until the Board determines a new NAV.
Investor Verification Checklist
- Verify the specific impact of the COVID-19 pandemic on the cash flows of the 17 properties switched to the Discounted Cash Flow method.
- Review the "Risk Factors" section of the Company's most recent Form 10-K (filed March 30, 2021) for detailed pandemic-related risks.
- Confirm the status of the four Michigan Shops and Florida properties (Jupiter and Wellington) which were valued at disposition prices and sold in Q1 2021.
- Understand that the $14.50 NAV is a point-in-time estimate and does not guarantee a resale price or liquidation proceeds for shareholders.
- Note that the valuation excludes a liquidity discount, which may be relevant if the Company were to list on a national exchange.